tiprankstipranks

Adam Craig Insider Profile

4 Followers
Adam Craig, EVP, Development & CMO at Viracta Therapeutics, holds 0.00 shares in CTI BioPharma (Ticker: CTIC), holds 23.45K shares in Viracta Therapeutics (Ticker: VIRX).
tipranks
Adam Craig

Adam Craig
Viracta Therapeutics (VIRX)
EVP, Development & CMO

Ranked #15,242 out of 99,805 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+191.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$12K
100.00%
A breakdown of Adam Craig's holdings

Insider Roles

Viracta Therapeutics
(VIRX)
EVP, Development & CMO
Roles that Adam Craig holds in companies

Most Profitable Insider Trade

Stock:
CTI BioPharma
(CTIC)
Rating:Informative Buy
Date:Dec 02, 2021 - Dec 02, 2022
Return:+315.90%
The most profitable trade made by Adam Craig

Adam Craig's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Viracta Therapeutics
Mar 02, 2015
EVP, Development & CMO
Uninformative Buy
$11.73K
CTIC
CTI BioPharma
Jun 26, 2023
Uninformative Sell
286.38K
$0.00
List of latest transactions for each holding click on a transaction to see Adam Craig's performance on stock

Adam Craig insider profile FAQ

What is the percentage of profitable transactions made by Adam Craig?
The percentage of profitable transactions made by Adam Craig is 100%.
    What is the average return per transaction made by Adam Craig?
    The average return per transaction made by Adam Craig is 191.90%.
      What stocks does Adam Craig hold?
      Adam Craig holds: VIRX, CTIC stocks.
        What was Adam Craig’s latest transaction?
        Adam Craig latest transaction was an Uninformative Sell of $286.38K.
          What was Adam Craig's most profitable transaction?
          Adam Craig’s most profitable transaction was an Informative Buy of CTIC stock on December 2, 2021. The return on the trade was 315.90%.
            What is Adam Craig's role in Viracta Therapeutics?
            Adam Craig's role in Viracta Therapeutics is EVP, Development & CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.